These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10181751)

  • 1. Pharmacoeconomics: determining the value of drug therapy.
    Peterson C
    Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.
    McGhan WF
    Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness data on biologics needed.
    Sheridan C; Katsnelson A
    Nat Biotechnol; 2005 Mar; 23(3):272-3. PubMed ID: 15765069
    [No Abstract]   [Full Text] [Related]  

  • 4. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic value of individualizing drug therapy.
    Navarro RP
    Manag Care Interface; 1997 Oct; 10(10):96-8. PubMed ID: 10174423
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA considers effects of managed care marketplace on drug promotional practices.
    Wechsler J
    Formulary; 1995 Dec; 30(12):840-1. PubMed ID: 10153083
    [No Abstract]   [Full Text] [Related]  

  • 7. User applications of health economics data.
    Navarro RP
    Med Interface; 1996 Mar; 9(3):81-2. PubMed ID: 10156017
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategic planning for applied pharmacoeconomics programs.
    Wanke LA; Ryan GM
    Pharm Pract Manag Q; 1996 Jan; 15(4):64-74. PubMed ID: 10153846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating disease state management and pharmaceutical care for cost-effective quality care.
    Dillon MJ
    Med Interface; 1995 Oct; 8(10):71, 79. PubMed ID: 10152325
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy: safety, effectiveness, and economics.
    Brandys J
    Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution?
    Alifrangis C; Krell J; Stebbing J
    Eur J Cancer; 2011 Jun; 47(9):1285-6. PubMed ID: 21550231
    [No Abstract]   [Full Text] [Related]  

  • 12. Medication restrictions: feeling the side effects.
    Fitzpatrick C
    Behav Healthc Tomorrow; 2001 Oct; 10(5):14-7, 39-40. PubMed ID: 11594068
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacoeconomics of high-cost biotechnology products.
    Dana WJ; Farthing K
    Pharm Pract Manag Q; 1998 Jul; 18(2):23-31. PubMed ID: 10185236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of randomized controlled trials in organizational decision making: a cost-minimization approach.
    Cher DJ; Maclure M
    Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why managed care should provide supportive therapies for cancer patients.
    Rubenstein SA
    Manag Care; 1995 Aug; 4(8):37-9. PubMed ID: 10145013
    [No Abstract]   [Full Text] [Related]  

  • 17. Serving patient needs while implementing cost effectiveness programs in health care administration.
    Tootelian DH
    Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing economic evaluations of drug therapy.
    Navarro RP
    Med Interface; 1996 Jul; 9(7):86-7, 92. PubMed ID: 10159281
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacoeconomics of acne treatment: where are we heading?
    Inglese MJ; Fleischer AB; Feldman SR; Balkrishnan R
    J Dermatolog Treat; 2008; 19(1):27-37. PubMed ID: 18273722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Special report: the value of pharmaceuticals. An "expensive" drug may be the most cost effective.
    Siegelman S
    Bus Health; 1991; [VALUE]():8-14. PubMed ID: 10170908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.